⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14079689 | 0.97 | — | — | |
| SCHEMBL769947 | 0.94 | — | — | |
| SCHEMBL18844703 | 0.89 | CES1 (0.30) | — | |
| SCHEMBL6432140 | 0.88 | — | — | |
| SCHEMBL25839164 | 0.87 | CYP1A2 (0.32) | — | |
| SCHEMBL21016180 | 0.85 | — | — | |
| SCHEMBL13824137 | 0.85 | TSHR (0.41) | — | |
| SCHEMBL21481531 | 0.83 | — | — | |
| SCHEMBL6505792 | 0.83 | — | — | |
| SCHEMBL26081550 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9988340-B2 | Compositions and methods for the treatment of multiple sclerosis | CELLIX BIO PRIVATE LIMITED (IN) | 2018-06-05 | — | — | US | disclosed |
| US-9932294-B2 | Compositions and methods for the treatment of multiple sclerosis | CELLIX BIO PRIVATE LIMITED (IN) | 2018-04-03 | — | — | US | disclosed |
| US-9771355-B2 | Compositions and methods for the treatment of epilepsy and neurological disorders | CELLIX BIO PRIVATE LIMITED (IN) | 2017-09-26 | — | — | US | disclosed |
| US-9765020-B2 | Dichlorophenyl-imino compounds and compositions, and methods for the treatment of mucositis | CELLIX BIO PRIVATE LIMITED (IN) | 2017-09-19 | — | — | US | disclosed |
| US-9738631-B2 | Compositions and methods for the treatment of neurological disorders | CELLIX BIO PRIVATE LIMITED (IN) | 2017-08-22 | — | — | US | disclosed |
| US-9670153-B2 | Compositions and methods for the treatment of inflammation and lipid disorders | CELLIX BIO PRIVATE LIMITED (IN) | 2017-06-06 | — | — | US | disclosed |
| US-9642915-B2 | Compositions and methods for the treatment of neuromuscular disorders and neurodegenerative diseases | CELLIX BIO PRIVATE LIMITED (IN) | 2017-05-09 | — | — | US | disclosed |
| US-9624168-B2 | Compositions and methods for the treatment inflammation and lipid disorders | CELLIX BIO PRIVATE LIMITED (IN) | 2017-04-18 | — | — | US | disclosed |
| US-9604920-B2 | Compositions and methods for the treatment of hyperglycemia and metabolic syndrome | ALAPATI MOHAN MURALI (IN) | 2017-03-28 | — | — | US | disclosed |
| US-9580383-B2 | Compositions and methods for the treatment of multiple sclerosis | CELLIX BIO PRIVATE LIMITED (IN) | 2017-02-28 | — | — | US | disclosed |
| US-20150119453-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION | CELLIX BIO PRIVATE LIMITED (IN) | 2015-04-30 | — | — | US | disclosed |
| US-20150119423-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF LOCAL PAIN | CELLIX BIO PRIVATE LIMITED (IN) | 2015-04-30 | — | — | US | disclosed |
| US-20150111966-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FIBROMYALGIA PAIN | CELLIX BIO PRIVATE LIMITED (IN) | 2015-04-23 | — | — | US | disclosed |
| US-20150111932-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROLOGICAL DEGENERATIVE DISORDERS | CELLIX BIO PRIVATE LIMITED (IN) | 2015-04-23 | — | — | US | disclosed |
| US-20150087660-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC DISEASES AND INFLAMMATORY DISORDERS | KANDULA MAHESH (IN) | 2015-03-26 | — | — | US | disclosed |
| US-20150087674-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEVERE PAIN | KANDULA MAHESH (IN) | 2015-03-26 | — | — | US | disclosed |
| US-20150087670-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF RESPIRATORY DISORDERS | CELLIX BIO PRIVATE LIMITED (IN) | 2015-03-26 | — | — | US | disclosed |
| US-20150080345-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC SYNDROME | CELLIX BIO PRIVATE LIMITED (IN) | 2015-03-19 | — | — | US | disclosed |
| US-20150057347-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATION AND LIPID DISORDERS | CELLIX BIO PRIVATE LIMITED (IN) | 2015-02-26 | — | — | US | disclosed |
| US-20120070994-A1 | RESIST UNDERLAYER FILM FORMING COMPOSITION CONTAINING SILICON HAVING SULFIDE BOND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-03-22 | — | — | US | disclosed |